Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03207009
Brief Title: A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Subjects With Transfusion-Dependent β-Thalassemia

First Submitted : June 29, 2017
First Submitted that Met QC Criteria : June 29, 2017
First Posted : July 2, 2017

Last Update Submitted that Met QC Criteria : June 23, 2021
Last Update Posted : June 24, 2021 (Estimate)